XXIVth French Virology Research Days

In 2022, the JFV are pleased to welcome the following:

• A "public" conference on Monday April 11^th in the evening by Sylvie Van der Werf : « from H5N1 to SARS-CoV-2 : what progress for future pandemics? ».
• A round-table discussion on « Scientifique Fraud & Misconduct»
(Elisabeth Bik, Olivier Le Gall, Yves Gaudin, Timothée Bruel).
• The attribution of prizes for the "best posters" and travel grants financed by the SFV and the SFM.
• An on-line one-year subscription to the journal "Virology " upon joining the SFV.

Conference Programme:

• Fabien Aubry : Zika virus : the African exception
• Charles Bachy : What do viral infections in small marine eucaryotes teach us?
• Anne-Sophie Beignon : Vaccines and innate immune memory.
• Claire Deback : Skin virome, from symbiosis to dysbiosis.
• Marianne De Paepe : Intestinal Virome: phages-bacteria interactions.
• Nolwenn Dheilly : The Russian Dolls : should we worry about viruses that infect parasites?
• Caroline Goujon : Innate and intrinsic antiviral defense mechanisms against SARS-CoV-2.
• Eugénie Hebrard : Contributions of interdisciplinary research on RYMV: ecology, epidemiology and pathogenesis.
• Nolwenn Jouvenet : Virus and Interferons : the clash of the Titans.
• Karim Majzoub : Hepatitis D Virus (HDV) and HDV-like agents in men and animals.
• Vincent Maréchal : Epidemiology in waste water during the COVID-19 outbreak: troubled water to improve our sight.
• Joao Trindade Marques : The virome of vector mosquitoes regulates arbovirus transmission.
• Mathieu Mateo : Issues and challenges of vaccination against Lassa fever.
• Sarah Merkling : The study of a phenotype for natural resistance against dengue fever virus in the Aedes aegypti mosquito.
• Sebastien Pfeffer : Double-strand RNA and innate antiviral immune response.
• Gwenael Piganeau : Phytoplankton-virus interactions through the genomic lens.
• Réjane Rua : Brain borders take center stage : role of meningeal macrophages in neuroinfection.
• Eloi Verrier : Hepatitus D Virus: host factors and new therapeutic targets.